Abstract

Organ tissue engineering, including cardiovascular tissues, has been an area of intense investigation. The major challenge to these approaches has been the inability to vascularize and perfuse the in vitro engineered tissue constructs. Attempts to provide oxygen and nutrients to the cells contained in the biomaterial constructs have had varying degrees of success. The aim of this current study is to develop a three-dimensional (3-D) model of vascularized cardiac tissue to examine the concurrent temporal and spatial regulation of cardiomyogenesis in the context of postnatal de novo vasculogenesis during stem cell cardiac regeneration. In order to achieve the above aim, we have developed an in vitro 3-D functional vascularized cardiac muscle construct using human induced pluripotent stem cell-derived embryonic cardiac myocytes (hiPSC-ECMs) and human mesenchymal stem cells (hMSCs). First, to generate the prevascularized scaffold, human cardiac microvascular endothelial cells (hCMVECs) and hMSCs were co-cultured onto a 3-D collagen cell carrier (CCC) for 7 days under vasculogenic culture conditions. In this milieu, hCMVECs/hMSCs underwent maturation, differentiation, and morphogenesis characteristic of microvessels, and formed extensive plexuses of vascular networks. Next, the hiPSC-ECMs and hMSCs were co-cultured onto this generated prevascularized CCCs for further 7 or 14 days in myogenic culture conditions. Finally, the vascular and cardiac phenotypic inductions were analyzed at the morphological, immunological, biochemical, molecular, and functional levels. Expression and functional analyses of the differentiated cells revealed neo-angiogenesis and neo-cardiomyogenesis. Thus, our unique 3-D co-culture system provided us the apt in vitro functional vascularized 3-D cardiac patch that can be utilized for cellular cardiomyoplasty.

Highlights

  • Restricted myocardial regeneration after tissue injury and shortage of organs for transplantation are the principal constraints of conventional therapies (Soonpaa and Field, 1998)

  • Considering the fact that hiPSC-ECMs and human mesenchymal stem cells (hMSCs) may represent the cells of greatest potential for adult autologous and/or allogenic stem based cardiac regeneration, we have evaluated their integrative competence using developmental biology and tissue engineering principles. hiPSC-ECMs were seeded onto a 3-D biomimetic and biocompatible collagen cell carrier (CCC) scaffold together with human cardiac microvascular endothelial cells (hCMVECs) in the presence or absence of hMSCs

  • We report the development of a reproducible in vitro 3-D model of cardiomyogenesis, as well as the generation of an archetypical 3-D vascularized cardiac patch for cardiovascular tissue engineering purposes

Read more

Summary

Introduction

Restricted myocardial regeneration after tissue injury and shortage of organs for transplantation are the principal constraints of conventional therapies (Soonpaa and Field, 1998). Organ tissue engineering, including cardiovascular tissues, has been an area of intense investigation. Functional Vascularized Cardiac Muscle Construct engineered tissue constructs (Bursac et al, 1999; Zimmermann et al, 2000; Papadaki et al, 2001). Engineering a tissue of clinically relevant magnitude requires the formation of an extensive and stable microvascular networks within the tissue. Since most in vitro engineered tissue constructs do not contain the intricate microvascular structures resembling those of native tissue, the cells contained in scaffolds heavily rely on simple diffusion for oxygenation and nutritional delivery (Zimmermann et al, 2000). Attempts to provide oxygen and nutrients to the cells contained in the biomaterial constructs have had varying degrees of success. Strategies aiming at the improvement of neovascularization of engineered tissues are of critical importance

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call